Entrada Therapeutics Stock Predictions

Meet the Founder That's Revolutionizing Smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

TRDA
Entrada Therapeutics

Last Price:

$9.87

Seasonality Move:

1.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Google closes secret $20B deal with Apple to become iPhone's default search engine

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Entrada Therapeutics Stock Forecast

Over the next 52 weeks, Entrada Therapeutics has on average historically risen by 8.1% based on the past 3 years of stock performance.
Entrada Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Is Entrada Therapeutics Stock Undervalued?

The current Entrada Therapeutics [TRDA] share price is $10.18. The Score for TRDA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
TRDA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Entrada Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Entrada Therapeutics has on average historically risen by 8.1% based on the past 3 years of stock performance.

Entrada Therapeutics Stock Rating

Sell

Entrada Therapeutics (TRDA) is a Sell

Is Entrada Therapeutics overpriced?

Entrada Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Entrada Therapeutics Stock Price History

Is TRDA stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

entradatx.com

52-Week Data

52-Week High:

21.79

52-Week Low:

10.08

Prediction Charts

Market Cap:

382.5M

Price in USD:

10.18

Volume:

66.9K

Beta:

-0.14

Technical Analysis

SMA50:

12.30

SMA100:

15.42

SMA200:

15.64

52-Wk Change:

-23.95%

Stock Predictions

Is Entrada Therapeutics stock public?

Yes, Entrada Therapeutics is a publicly traded company.
What is the Entrada Therapeutics stock quote today?

The Entrada Therapeutics stock price is 10.18 USD today.
How to buy Entrada Therapeutics stock online?

You can buy Entrada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-6	10.37	10.42	10.83	10.26
Mar-7	10.47	10.77	11.04	10.45
Mar-11	10.49	10.65	10.73	10.22
Mar-12	10.74	11.22	11.27	10.64
Mar-13	11.23	10.82	11.36	10.80
Mar-14	10.95	10.81	11.14	10.76
Mar-17	10.67	10.81	11.36	10.53
Mar-18	10.66	10.46	10.74	10.28
Mar-19	10.52	10.75	10.78	10.31
Mar-20	10.59	10.41	11.04	10.37
Mar-21	10.27	10.49	10.80	10.15
Mar-24	10.63	10.80	10.81	10.61
Mar-25	10.76	10.18	10.87	10.08
Mar-26	10.07	9.90	10.29	9.75

Entrada Therapeutics Earnings

Entrada Therapeutics Earnings Report: Per Share Entrada Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Entrada Therapeutics Forecast Revenue Growth

Entrada Therapeutics Stock Analysis: Historical quarterly revenues per share for Entrada Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.15 per share, a decrease this year of $4.02 per share, and a decrease next year of $0.30 per share.

* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.